207 related articles for article (PubMed ID: 18242117)
1. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
Paget V; Lechevrel M; Sichel F
Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
[TBL] [Abstract][Full Text] [Related]
2. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
Paget V; Sichel F; Garon D; Lechevrel M
Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
[TBL] [Abstract][Full Text] [Related]
3. Benzene-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the functional analysis of separated alleles in yeast, in human lung cells.
Billet S; Paget V; Garçon G; Heutte N; André V; Shirali P; Sichel F
Arch Toxicol; 2010 Feb; 84(2):99-107. PubMed ID: 19862502
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of chemically-induced mutations at the flounder TP53 locus, the FACIM assay.
Cachot J; Couteau J; Frébourg T; Leboulenger F; Flaman JM
Mutat Res; 2004 Aug; 552(1-2):51-60. PubMed ID: 15288541
[TBL] [Abstract][Full Text] [Related]
5. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
7. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
[TBL] [Abstract][Full Text] [Related]
8. Mutations induced by 1-nitrosopyrene and related compounds during DNA replication in human cells and induction of homologous recombination by these compounds.
Maher VM; Bhattacharyya NP; Mah MC; Boldt J; Yang JL; McCormick JJ
Res Rep Health Eff Inst; 1993 Mar; (55):1-40; discussion 41-51. PubMed ID: 8466678
[TBL] [Abstract][Full Text] [Related]
9. TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America.
Szymańska K; Levi JE; Menezes A; Wünsch-Filho V; Eluf-Neto J; Koifman S; Matos E; Daudt AW; Curado MP; Villar S; Pawlita M; Waterboer T; Boffetta P; Hainaut P; Brennan P
Carcinogenesis; 2010 Jun; 31(6):1054-9. PubMed ID: 19955396
[TBL] [Abstract][Full Text] [Related]
10. DNA damage and mutations produced by chloroacetaldehyde in a CpG-methylated target gene.
Choi JH; Pfeifer GP
Mutat Res; 2004 Dec; 568(2):245-56. PubMed ID: 15542111
[TBL] [Abstract][Full Text] [Related]
11. p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients.
Osugi H; Morimura K; Okuda E; Takemura M; Higashino M; Takada N; Kinoshita H
Int J Oncol; 2002 Sep; 21(3):637-41. PubMed ID: 12168111
[TBL] [Abstract][Full Text] [Related]
12. Molecular etiopathogenesis of esophageal cancers.
Montesano R; Hollstein M; Hainaut P
Ann Ist Super Sanita; 1996; 32(1):73-84. PubMed ID: 8967725
[TBL] [Abstract][Full Text] [Related]
13. Sequence distribution of acetaldehyde-derived N2-ethyl-dG adducts along duplex DNA.
Matter B; Guza R; Zhao J; Li ZZ; Jones R; Tretyakova N
Chem Res Toxicol; 2007 Oct; 20(10):1379-87. PubMed ID: 17867647
[TBL] [Abstract][Full Text] [Related]
14. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene, aflatoxine B₁ and acetaldehyde mutational patterns in TP53 gene using a functional assay: relevance to human cancer aetiology.
Paget V; Lechevrel M; André V; Goff JL; Pottier D; Billet S; Garçon G; Shirali P; Sichel F
PLoS One; 2012; 7(2):e30921. PubMed ID: 22319594
[TBL] [Abstract][Full Text] [Related]
16. TP53 and oesophageal cancer.
Ferec C; Giroux MA; Audrezet MP; Robaszkiewicz M
Pathol Biol (Paris); 1997 Dec; 45(10):871-5. PubMed ID: 9769951
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.
Watanabe J; Nishiyama H; Okubo K; Takahashi T; Toda Y; Habuchi T; Kakehi Y; Tada M; Ogawa O
Urology; 2004 May; 63(5):989-93. PubMed ID: 15135005
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.
Deissler H; Kafka A; Schuster E; Sauer G; Kreienberg R; Zeillinger R
Oncol Rep; 2004 Jun; 11(6):1281-6. PubMed ID: 15138567
[TBL] [Abstract][Full Text] [Related]
19. Mutant frequency and mutational spectra in the Tk and Hprt genes of N-ethyl-N-nitrosourea-treated mouse lymphoma cellsdagger.
Chen T; Harrington-Brock K; Moore MM
Environ Mol Mutagen; 2002; 39(4):296-305. PubMed ID: 12112381
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of mouse p53 yeast functional assay and evaluation of its detectability of p53 gene mutation].
Tsunematsu I
Hokkaido Igaku Zasshi; 1999 Jul; 74(4):301-14. PubMed ID: 10480037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
